Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates

Axsome Therapeutics (AXSM) came out with a quarterly loss of $1.34 per share versus the Zacks Consensus Estimate of a loss of$ 1.38. This compares to loss of $1.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.90%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 1.30 per share when it actually produced a loss of $1.24, delivering a surprise of 4.62%.Over the last four quarters, the ...